Report of the pediatric heart network and national heart, lung, and blood institute working group on the perioperative management of congenital heart disease

Circulation

Volumn 121, Issue 25, 2010, Pages 2766-2772

  Kaltman, Jonathan R ^a   Andropoulos, Dean B ^b   Checchia, Paul A ^c   Gaynor, J William ^d   Hoffman, Timothy M ^e   Laussen, Peter C ^f   Ohye, Richard G ^g   Pearson, Gail D ^a   Pigula, Frank ^f   Tweddell, James ^h   Wernovsky, Gil ^d   Del Nido, Pedro ^f  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b Texas Children's Hospital   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^e NATIONWIDE CHILDREN S HOSPITAL   (United States)

^f BOSTON CHILDREN S HOSPITAL   (United States)

^g UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^h Children's Hospital of Wisconsin   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOINFORMATICS; BRAIN PERFUSION; CARDIOPULMONARY BYPASS; CONGENITAL HEART DISEASE; DEEP HYPOTHERMIC CIRCULATORY ARREST; DISEASE REGISTRY; FALLOT TETRALOGY; GENETIC POLYMORPHISM; GENOTYPE; HEALTH CARE QUALITY; HEART INFARCTION PREVENTION; HEREDITY; HUMAN; MEDICAL INSTRUMENTATION; MEDICAL PRACTICE; MEDICAL TECHNOLOGY; MORTALITY; NERVOUS SYSTEM DEVELOPMENT; NEUROMONITORING; PEDIATRIC SURGERY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

CARDIOPULMONARY BYPASS; CHILD; CLINICAL TRIALS AS TOPIC; GENOMICS; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; PERIOPERATIVE CARE; PHYSICIAN'S PRACTICE PATTERNS; TECHNOLOGY;

EID: 77954235407     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.913129     Document Type: Review

References (51)

1. Kids' Inpatient Database. Rockville, Md: Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality; 1997, 2000, 2003, 2006. Available at: http://www.hcup-us.ahrq.gov/kidoverview.jsp. Accessed September 1, 2009.
2. Norwood WI, Lang P, Hansen DD. Physiologic repair of aortic atresia-hypoplastic left heart syndrome. N Engl J Med. 1983;308:23-26.
3. Sano S, Ishino K, Kawada M, Arai S, Kasahara S, Asai T, Masuda Z, Takeuchi M, Ohtsuki S. Right ventricle-pulmonary artery shunt in first-stage palliation of hypoplastic left heart syndrome. J Thorac Cardiovasc Surg. 2003;126:504-509.
4. Wernovsky G, Ghanayem N, Ohye RG, Bacha EA, Jacobs JP, Gaynor JW, Tabbutt S. Hypoplastic left heart syndrome: consensus and controversies in 2007. Cardiol Young. 2007;17(suppl 2):75-86. (Pubitemid 350237747)
5. Scheurer MA, Salvin JW, Vida VL, Fynn-Thompson F, Bacha EA, Pigula FA, Mayer JE Jr, del Nido PJ, Wessel DL, Laussen PC, Thiagarajan RR. Survival and clinical course at Fontan after stage one palliation with either a modified Blalock-Taussig shunt or a right ventricle to pulmonary artery conduit. J Am Coll Cardiol. 2008;52:52-59.
6. Ballweg JA, Dominguez TE, Ravishankar C, Kreutzer J, Marino BS, Bird GL, Gruber PJ, Wernovsky G, Gaynor JW, Nicolson SC, Spray TL, Tabbutt S. A contemporary comparison of the effect of shunt type in hypoplastic left heart syndrome on the hemodynamics and outcome at stage 2 reconstruction. J Thorac Cardiovasc Surg. 2007;134:297-303.
7. Caspi J, Pettitt TW, Mulder T, Stopa A. Development of the pulmonary arteries after the Norwood procedure: comparison between Blalock-Taussig shunt and right ventricular-pulmonary artery conduit. Ann Thorac Surg. 2008;86:1299-1304.
8. Ohye RG, Gaynor JW, Ghanayem NS, Goldberg CS, Laussen PC, Frommelt PC, Newburger JW, Pearson GD, Tabbutt S, Wernovsky G, Wruck LM, Atz AM, Colan SD, Jaggers J, McCrindle BW, Prakash A, Puchalski MD, Sleeper LA, Stylianou MP, Mahony L. Design and rationale of a randomized trial comparing the Blalock-Taussig and right ventricle-pulmonary artery shunts in the Norwood procedure. J Thorac Cardiovasc Surg. 2008;136:968-975.
9. Odegard KC, Zurakowski D, DiNardo JA, Castro RA, McGowan FX Jr, Neufeld EJ, Laussen PC. Prospective longitudinal study of coagulation profiles in children with hypoplastic left heart syndrome from stage I through Fontan completion. J Thorac Cardiovasc Surg. 2009;137: 934-941.
10. Guzzetta NA, Bajaj T, Fazlollah T, Szlam F, Wilson E, Kaiser A, Tosone SR, Miller BE. A comparison of heparin management strategies in infants undergoing cardiopulmonary bypass. Anesth Analg. 2008;106:419-425.
11. Koster A, Chew D, Kuebler W, Habazettl H, Hetzer R, Kuppe H. High antithrombin III levels attenuate hemostatic activation and leukocyte activation during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2003;126:906-907.
12. Avidan MS, Levy JH, van Aken H, Feneck RO, Latimer RD, Ott E, Martin E, Birnbaum DE, Bonfiglio LJ, Kajdasz DK, Despotis GJ. Recom-binant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2005;130:107-113.
13. Teoh LK, Grant R, Hulf JA, Pugsley WB, Yellon DM. The effect of preconditioning (ischemic and pharmacological) on myocardial necrosis following coronary artery bypass graft surgery. Cardiovasc Res. 2002; 53:175-180.
14. Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P. Regional ischemic "preconditioning" protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation. 1993;87:893-899.
15. Konstantinov IE, Arab S, Kharbanda RK, Li J, Cheung MM, Cherepanov V, Downey GP, Liu PP, Cukerman E, Coles JG, Redington AN. The remote ischemic preconditioning stimulus modifies inflammatory gene expression in humans. Physiol Genomics. 2004;19:143-150. (Pubitemid 40039920)
16. Cheung MM, Kharbanda RK, Konstantinov IE, Shimizu M, Frndova H, Li J, Holtby HM, Cox PN, Smallhorn JF, Van Arsdell GS, Redington AN. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol. 2006;47:2277-2282.
17. Licht DJ, Shera DM, Clancy RR, Wernovsky G, Montenegro LM, Nicolson SC, Zimmerman RA, Spray TL, Gaynor JW, Vossough A. Brain maturation is delayed in infants with complex congenital heart defects. J Thorac Cardiovasc Surg. 2009;137:529-536.
18. Derby CD, Pizarro C. Routine primary repair of tetralogy of Fallot in the neonate. Expert Rev Cardiovasc Ther. 2005;3:857-863.
19. Hirsch JC, Charpie JR, Ohye RG, Gurney JG. Near-infrared spec-troscopy: what we know and what we need to know: a systematic review of the congenital heart disease literature. J Thorac Cardiovasc Surg. 2009;137:154-159, 159e1-159e112.
20. Sherlock RL, McQuillen PS, Miller SP. Preventing brain injury in newborns with congenital heart disease: brain imaging and innovative trial designs. Stroke. 2009;40:327-332.
21. Forbess JM, Visconti KJ, Hancock-Friesen C, Howe RC, Bellinger DC, Jonas RA. Neurodevelopmental outcome after congenital heart surgery: results from an institutional registry. Circulation. 2002;106(suppl): I-95-I-102.
22. Wypij D, Newburger JW, Rappaport LA, duPlessis AJ, Jonas RA, Wernovsky G, Lin M, Bellinger DC. The effect of duration of deep hypothermic circulatory arrest in infant heart surgery on late neurodevel-opment: the Boston Circulatory Arrest Trial. J Thorac Cardiovasc Surg. 2003;126:1397-1403.
23. Utens EM, Verhulst FC, Duivenvoorden HJ, Meijboom FJ, Erdman RA, Hess J. Prediction of behavioural and emotional problems in children and adolescents with operated congenital heart disease. Eur Heart J. 1998; 19:801-807.
24. Asou T, Kado H, Imoto Y, Shiokawa Y, Tominaga R, Kawachi Y, Yasui H. Selective cerebral perfusion technique during aortic arch repair in neonates. Ann Thorac Surg. 1996;61:1546-1548.
25. Ohye RG, Goldberg CS, Donohue J, Hirsch JC, Gaies M, Jacobs ML, Gurney JG. The quest to optimize neurodevelopmental outcomes in neonatal arch reconstruction: the perfusion techniques we use and why we believe in them. J Thorac Cardiovasc Surg. 2009;137:803-806.
26. Goldberg CS, Bove EL, Devaney EJ, Mollen E, Schwartz E, Tindall S, Nowak C, Charpie J, Brown MB, Kulik TJ, Ohye RG. A randomized clinical trial of regional cerebral perfusion versus deep hypothermic circulatory arrest: outcomes for infants with functional single ventricle. J Thorac Cardiovasc Surg. 2007;133:880-887.
27. McQuillen PS, Barkovich AJ, Hamrick SE, Perez M, Ward P, Glidden DV, Azakie A, Karl T, Miller SP. Temporal and anatomic risk profile of brain injury with neonatal repair of congenital heart defects. Stroke. 2007;38:736-741.
28. Cleves MA, Ghaffar S, Zhao W, Mosley BS, Hobbs CA. First-year survival of infants born with congenital heart defects in Arkansas (1993-1998): a survival analysis using registry data. Birth Defects Res A Clin Mol Teratol. 2003;67:662-668.
29. Ziolkowska L, Kawalec W, Turska-Kmiec A, Krajewska-Walasek M, Brzezinska-Rajszys G, Daszkowska J, Maruszewski B, Burczynski P. Chromosome 22q11.2 microdeletion in children with conotruncal heart defects: frequency, associated cardiovascular anomalies, and outcome following cardiac surgery. Eur J Pediatr. 2008;167:1135-1140.
30. Atallah J, Joffe AR, Robertson CM, Leonard N, Blakley PM, Nettel-Aguirre A, Sauve RS, Ross DB, Rebeyka IM. Two-year general and neurodevelopmental outcome after neonatal complex cardiac surgery in patients with deletion 22q11.2: a comparative study. J Thorac Cardiovasc Surg. 2007;134:772-779.
31. Gaynor JW, Nord AS, Wernovsky G, Bernbaum J, Solot CB, Burnham N, Zackai E, Heagerty PJ, Clancy RR, Nicolson SC, Jarvik GP, Gerdes M. Apolipoprotein E genotype modifies the risk of behavior problems after infant cardiac surgery. Pediatrics. 2009;124:241-250.
32. Podgoreanu MV, Schwinn DA. New paradigms in cardiovascular medicine: emerging technologies and practices: perioperative genomics. J Am Coll Cardiol. 2005;46:1965-1977.
33. Galley HF, Lowe PR, Carmichael RL, Webster NR. Genotype and interleukin-10 responses after cardiopulmonary bypass. Br J Anaesth. 2003;91:424-426.
34. Faraday N, Martinez EA, Scharpf RB, Kasch-Semenza L, Dorman T, Pronovost PJ, Perler B, Gerstenblith G, Bray PF, Fleisher LA. Platelet gene polymorphisms and cardiac risk assessment in vascular surgical patients. Anesthesiology. 2004;101:1291-1297.
35. Manolio TA, Collins FS. The HapMap and genome-wide association studies in diagnosis and therapy. Annu Rev Med. 2009;60:443-456.
36. Goldmuntz E, Geiger E, Benson DW. NKX2.5 mutations in patients with tetralogy of Fallot. Circulation. 2001;104:2565-2568.
37. Tomita-Mitchell A, Maslen CL, Morris CD, Garg V, Goldmuntz E. GATA4 sequence variants in patients with congenital heart disease. J Med Genet. 2007;44:779-783.
38. Kaltman JR, Schramm C, Pearson GD. The National Heart, Lung, and Blood Institute Bench to Bassinet Program: a new paradigm for transla-tional research. J Am Coll Cardiol. 2010;55:1262-1265.
39. Almond CS, Chen EA, Berman MR, Less JR, Baldwin JT, Linde-Feucht SR, Hoke TR, Pearson GD, Jenkins K, Duncan BW, Zuckerman BD. High-risk medical devices, children and the FDA: regulatory challenges facing pediatric mechanical circulatory support devices. ASAIO J. 2007; 53:4-7.
40. Cikirikcioglu M, Pektok E, Myers PO, Christenson JT, Kalangos A. Pediatric mitral valve repair with the novel annuloplasty ring: Kalangos-Bioring. Asian Cardiovasc Thorac Ann. 2008;16:515-516.
41. Kalangos A, Christenson JT, Beghetti M, Cikirikcioglu M, Kamentsidis D, Aggoun Y. Mitral valve repair for rheumatic valve disease in children: midterm results and impact of the use of a biodegradable mitral ring. Ann Thorac Surg. 2008;86:161-168.
42. Von Eschenbach AC, Buetow B. Cancer informatics vision: caBIG. Cancer Informatics. 2006;2:22-24.
43. Jacobs JP, Mavroudis C, Jacobs ML, Maruszewski B, Tchervenkov CI, Lacour-Gayet FG, Clarke DR, Gaynor JW, Spray TL, Kurosawa H, Stellin G, Ebels T, Bacha EA, Walters HL III, Elliott MJ. Nomenclature and databases: the past, the present, and the future: a primer for the congenital heart surgeon. Pediatr Cardiol. 2007;28:105-115.
44. McQuillen PS. Magnetic resonance imaging in congenital heart disease: what to do with what we see and don't see? Circulation. 2009;119: 660-662.
45. Wright LL, Verter J, Younes N, Stevenson D, Fanaroff AA, Shankaran S, Ehrenkranz RA, Donovan EF. Antenatal corticosteroid administration and neonatal outcome in very low birth weight infants: the NICHD Neonatal Research Network. Am J Obstet Gynecol. 1995;173:269-274.
46. Moscucci M, Rogers EK, Montoye C, Smith DE, Share D, O'Donnell M, Maxwell-Eward A, Meengs WL, De Franco AC, Patel K, McNamara R, McGinnity JG, Jani SM, Khanal S, Eagle KA. Association of a continuous quality improvement initiative with practice and outcome variations of contemporary percutaneous coronary interventions. Circulation. 2006;113:814-822.
47. O'Connor GT, Plume SK, Olmstead EM, Morton JR, Maloney CT, Nugent WC, Hernandez F Jr, Clough R, Leavitt BJ, Coffin LH, Marrin CA, Wennberg D, Birkmeyer JD, Charlesworth DC, Malenka DJ, Quinton HB, Kasper JF. A regional intervention to improve the hospital mortality associated with coronary artery bypass graft surgery: the Northern New England Cardiovascular Disease Study Group. JAMA. 1996;275:841-846.
48. Jonas RA, Wypij D, Roth SJ, Bellinger DC, Visconti KJ, du Plessis AJ, Goodkin H, Laussen PC, Farrell DM, Bartlett J, McGrath E, Rappaport LJ, Bacha EA, Forbess JM, del Nido PJ, Mayer JE Jr, Newburger JW. The influence of hemodilution on outcome after hypothermic cardio-pulmonary bypass: results of a randomized trial in infants. J Thorac Cardiovasc Surg. 2003;126:1765-1774.
49. Walsh MC. Benchmarking techniques to improve neonatal care: uses and abuses. Clin Perinatol. 2003;30:343-350, x
50. Dokholyan RS, Muhlbaier LH, Falletta JM, Jacobs JP, Shahian D, Haan CK, Peterson ED. Regulatory and ethical considerations for linking clinical and administrative databases. Am Heart J. 2009;157:971-982.
51. Horbar JD. The Vermont Oxford Network: evidence-based quality improvement for neonatology. Pediatrics. 1999;103:350-359.